| Date Checked | 2025-12-21 23:40:39 |
|---|---|
| Graham Number | (PB)4.62 vs (PE)22.40 |
| Over / Under Value Percentage | 371.16% vs -13.18% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | ELAN |
| AssetType | Common Stock |
| Name | Elanco Animal Health |
| Description | Elanco Animal Health Incorporated (ELAN) is a leading global entity in the animal health industry, dedicated to improving the health and productivity of both companion animals and livestock. Headquartered in Greenfield, Indiana, Elanco boasts a comprehensive portfolio of scientifically advanced products tailored to address the dynamic needs of veterinarians and producers worldwide. The company prioritizes research and sustainable practices, positioning itself strategically to capitalize on the growing global demand for innovative animal health solutions. Through proactive investments in innovation, Elanco aims to drive significant growth while enhancing animal welfare and improving efficiencies within the food supply chain. |
| CIK | 1739104 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Address | 2500 INNOVATION WAY, GREENFIELD, IN, UNITED STATES, 46140 |
| OfficialSite | https://www.elanco.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 11080056000 |
| EBITDA | 882000000 |
| PERatio | 318.57 |
| PEGRatio | 3.861 |
| BookValue | 13.58 |
| DividendPerShare | None |
| EPS | 0.07 |
| RevenuePerShareTTM | 9.26 |
| ProfitMargin | 0.0078 |
| OperatingMarginTTM | 0.0238 |
| ReturnOnAssetsTTM | 0.0115 |
| ReturnOnEquityTTM | 0.0054 |
| RevenueTTM | 4591000000 |
| GrossProfitTTM | 2523000000 |
| DilutedEPSTTM | 0.07 |
| QuarterlyEarningsGrowthYOY | 1.167 |
| QuarterlyRevenueGrowthYOY | 0.104 |
| AnalystTargetPrice | 25 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 10 |
| AnalystRatingHold | 3 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 1 |
| TrailingPE | 318.57 |
| ForwardPE | 21.23 |
| PriceToSalesRatioTTM | 2.413 |
| PriceToBookRatio | 1.642 |
| EVToRevenue | 3.18 |
| EVToEBITDA | 17.38 |
| Beta | 1.861 |
| 52WeekHigh | 23.7 |
| 52WeekLow | 8.02 |
| 50DayMovingAverage | 21.79 |
| 200DayMovingAverage | 16.0 |
| SharesOutstanding | 496863000 |
| SharesFloat | 492819000 |
| PercentInsiders | 1.072 |
| PercentInstitutions | 116.416 |
| ExDividendDate | None |
| dateChecked | 2025-12-21 23:40:39 |
| fresh | 1 |